VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Republic Services, Inc. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Republic Services, Inc.
RSG · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Republic Services, Inc.'s moat claims, evidence, and risks.
View RSG analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Republic Services, Inc. leads (80 / 100 vs 74 / 100 for Sanofi).
- Segment focus: Republic Services, Inc. has 2 segments (88.5% in Recycling & Waste Services); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Moderate.
- Moat breadth: Republic Services, Inc. has 7 moat types across 3 domains; Sanofi has 5 across 3.
Primary market context
Republic Services, Inc.
Recycling & Waste Services
Integrated non-hazardous solid waste collection, transfer, landfill disposal & recycling services
United States and Canada
Municipal, commercial, industrial
Integrated hauler and disposal operator
88.5%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Republic Services, Inc. strengths
Sanofi strengths
Segment mix
Republic Services, Inc. segments
Full profile >Recycling & Waste Services
Competitive
Environmental Solutions
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.